Novel Drug Discovery & Development: How Federal Policymakers Look at Pricing

August 5, 2020 | 4:30pm-5:30pm ET

As the world waits for a SARS-CoV-2 vaccine, federal funding of biomedical research is more crucial than ever. During this COVID-19 pandemic, the National Institutes of Health (NIH) is committed to supporting not only the development of novel drugs to treat this virus but to continuing to fund the research of other groundbreaking vaccines, medicines, and therapies. Yet as new treatments to enhance – or save – our lives are discovered, how are the pricing structures determined?

In this interview-style webinar, Rep. Rosa DeLauro (D-CT), Chair of the Labor, Health and Human Services, and Education Appropriations Subcommittee, joins Triumvirate Environmental CEO John F. McQuillan for a dynamic discussion on novel drug development and pricing.

During this interview, Rep. DeLauro and Mr. McQuillan will explore topics
such as:

  • What curatives are available to treat COVID-19
  • How states are handling shortages of COVID-19 testing supplies, N95 respirators, and other PPE
  • Why NIH funding is paramount during the COVID-19 pandemic
  • How the availability of NIH funding affects an organization’s ability to advance its research
  • What appropriations are necessary to fund novel drugs and therapies
  • How federal policymakers are analyzing pricing structures and the affordability of novel drugs
  • And more…

To register, please complete the form. You are encouraged to submit questions for Rep. DeLauro and Mr. McQuillan as you register. There will not be an opportunity to ask questions live during the event.

We're sorry, this event has passed. Please visit our webinar archives.

Rep. Rosa DeLauro (D-CT)

About the Speaker

Rep. Rosa DeLauro (D-CT)
United States House of Representatives

Rosa DeLauro is the Congresswoman from Connecticut’s Third Congressional District, which stretches from the Long Island Sound and New Haven, to the Naugatuck Valley and Waterbury. Rosa serves in the Democratic leadership as Co-Chair of the Democratic Steering and Policy Committee, and she is the Chair of the Labor, Health and Human Services, and Education Appropriations Subcommittee, where she oversees our nation’s investments in education, health, and employment. Rosa also serves on the subcommittee responsible for the U.S. Department of Agriculture and the U.S. Food and Drug Administration, where she oversees food and drug safety.

At the core of Rosa’s work is her fight for America’s working families. Rosa believes that we must raise the nation’s minimum wage, give all employees access to paid sick days, allow employees to take paid family and medical leave, and ensure equal pay for equal work. Every day, Rosa fights for legislation that would give all working families an opportunity to succeed. Rosa believes that our first priority must be to strengthen the economy and create good middle-class jobs. She supports tax cuts for working- and middle-class families, fought to expand the Child Tax Credit to provide tax relief to millions of families, and introduced the Young Child Tax Credit to give families with young children an economic lift.

As the Chair dealing with appropriations for Labor, Health, Human Services, and Education, Rosa is determined to increase support for education and make college more affordable for more American students and their families. She is also fighting to protect the Affordable Care Act so that all Americans have access to affordable care. Rosa strongly believes in the power of biomedical research and she is working to increase funding so that we can make lifesaving breakthroughs in science and medicine.

John McQuillan

John F. McQuillan
Chairman & CEO, Triumvirate Environmental, Inc.

John McQuillan serves as Chairman and CEO of the company he founded 32 years ago, Triumvirate Environmental, an environmental advisor on complex environmental solutions, benefitting some eight hundred billion dollars in customer assets. In addition to his professional pursuits, John has advised more than 100 political campaigns and serves or has served as director, trustee, or patron for more than 50 mission-driven organizations, concentrated in the areas of: excellence in education, healthcare, environmental protection, workforce development, and scientific discovery.

John earned a master’s degree from Harvard University and an A.B. from Bowdoin College in biochemistry. In his leisure time, he enjoys science, politics, and the arts, as well as reading, angel investing, Boston sports, skiing, and travel. John lives in Cambridge with his wife and daughters.